✦ LIBER ✦

Human brain tumor imaging with a protein-binding MR contrast agent: initial experience

✍ Scribed by Marco Essig; Martin Rohrer; Frederik Giesel; Jochen Tüttenberg; Marc-André Weber; Hendrik Michaely; Lars Gerigk; Matthias Voth

Book ID: 113032327
Publisher: Springer
Year: 2009
Tongue: English
Weight: 393 KB
Volume: 20
Category: Article
ISSN: 0938-7994
DOI: 10.1007/s00330-009-1530-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved delineation of human brain tumo

Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent

✍ W. Scott Enochs; Griffith Harsh; Fred Hochberg; Ralph Weissleder 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

CMR2009: 3.03: Oral manganese-based cont

CMR2009: 3.03: Oral manganese-based contrast agent CMC-001 for liver MR imaging in patients with hepatic metastases: initial experience of a phase II trial

✍ M. Rief; P. Asbach; T. Franiel; M. Taupitz; B. Hamm; M. Wagner 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Initial clinical experience with gadolin

Initial clinical experience with gadolinium bopta/dimeg: A new hepatobiliary specific contrast agent for magnetic resonance imaging (MRI) of the liver

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Contrast-enhanced MR imaging of liver an

Contrast-enhanced MR imaging of liver and spleen: First experience in humans with a new superparamagnetic iron oxide

✍ Bernd Hamm; Thomas Staks; Matthias Taupitz; Renate Maibauer; Andrea Speidel; Ale 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1005 KB

## Abstract The aim of this prospective study was to obtain the first human safety and magnetic resonance (MR) imaging results with a new formulation of superparamagnetic iron oxide (SPIO) (SHU 555 A). The SPIO was tested at four iron doses, from 5 to 40 μmol/kg. Laboratory tests and clinical measu

Evaluation of CH3-DTPA-Gd (NMS60) as a n

Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging

✍ Masato Ito; Hiroyuki Ogino; Hidekazu Oshima; Norio Shiraki; Yuta Shibamoto; Haru 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Combined morphological, [1H]-MR spectros

Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience

✍ M. Carlani; S. Mancino; E. Bonanno; E. Finazzi Agrò; G. Simonetti 📂 Article 📅 2008 🏛 Springer 🌐 Italian ⚖ 993 KB